eIF5 (Figure 3F) expression showed a high variability throughout all samples and eIF6 (IV: p < 0.01; Figure 3G) expression was only elevated in high grade gliomas (HGGs) compared to CCBT. This evidence concerns the gene EIF6 and central nervous system cancer.